PDS Biotechnology Corp Increase Decrease In Operating Lease Liability
PDS Biotechnology Corp (PDSB) reported Increase Decrease In Operating Lease Liability of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-03-30
- PDS Biotechnology Corp increase decrease in operating lease liability for the quarter ending 2024-12-31 was $0.00.
- PDS Biotechnology Corp increase decrease in operating lease liability for the quarter ending 2024-09-30 was $0.00.
- PDS Biotechnology Corp increase decrease in operating lease liability for the quarter ending 2024-06-30 was $0.00.
- PDS Biotechnology Corp increase decrease in operating lease liability for the quarter ending 2024-03-31 was $0.00.
- PDS Biotechnology Corp increase decrease in operating lease liability for fiscal 2025 was $0.00.
- PDS Biotechnology Corp increase decrease in operating lease liability for fiscal 2024 was $0.00.
- PDS Biotechnology Corp increase decrease in operating lease liability for fiscal 2023 was -$239.47K.
- PDS Biotechnology Corp increase decrease in operating lease liability for fiscal 2022 was -$294.99K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-30 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $0.00 derived: sum of 2 quarters · filed 2026-03-30 | $0.00 derived: sum of 3 quarters · filed 2026-03-30 | $0.00 10-K · filed 2026-03-30 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | $0.00 10-Q · filed 2024-11-14 | $0.00 derived: sum of 4 quarters · filed 2025-03-27 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $0.00 10-Q · filed 2024-08-13 | $0.00 derived: sum of 3 quarters · filed 2025-03-27 | -$60.33K derived: sum of 4 quarters · filed 2025-03-27 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-15 | $0.00 derived: sum of 2 quarters · filed 2025-03-27 | -$60.33K derived: sum of 3 quarters · filed 2025-03-27 | -$150.37K derived: sum of 4 quarters · filed 2025-03-27 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$60.33K derived: sum of 2 quarters · filed 2025-03-27 | -$150.37K derived: sum of 3 quarters · filed 2025-03-27 | -$239.47K 10-K · filed 2025-03-27 |
| 2023-09-30 | -$60.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$150.37K derived: sum of 2 quarters · filed 2024-11-14 | -$239.47K 10-Q · filed 2024-11-14 | -$328.57K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | -$90.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$179.14K 10-Q · filed 2024-08-13 | -$268.24K derived: sum of 3 quarters · filed 2024-08-13 | -$357.34K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$89.10K 10-Q · filed 2024-05-15 | -$178.21K derived: sum of 2 quarters · filed 2024-05-15 | -$267.31K derived: sum of 3 quarters · filed 2024-05-15 | -$341.05K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | -$89.10K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$178.21K derived: sum of 2 quarters · filed 2024-03-28 | -$251.95K derived: sum of 3 quarters · filed 2024-03-28 | -$294.99K 10-K · filed 2024-03-28 |
| 2022-09-30 | -$89.10K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$162.85K derived: sum of 2 quarters · filed 2023-11-14 | -$205.88K 10-Q · filed 2023-11-14 | -$248.92K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | -$73.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$116.78K 10-Q · filed 2023-08-14 | -$159.82K derived: sum of 3 quarters · filed 2023-08-14 | -$203.51K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$43.04K 10-Q · filed 2023-05-15 | -$86.07K derived: sum of 2 quarters · filed 2023-05-15 | -$129.76K derived: sum of 3 quarters · filed 2023-05-15 | -$171.82K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | -$43.03K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | -$86.72K derived: sum of 2 quarters · filed 2023-03-28 | -$128.78K derived: sum of 3 quarters · filed 2023-03-28 | -$170.84K 10-K · filed 2023-03-28 |
| 2021-09-30 | -$43.69K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$85.75K derived: sum of 2 quarters · filed 2022-11-14 | -$127.80K 10-Q · filed 2022-11-14 | -$163.34K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$42.06K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$84.11K 10-Q · filed 2022-08-08 | -$119.65K derived: sum of 3 quarters · filed 2022-08-08 | -$166.60K derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | -$42.06K 10-Q · filed 2022-05-11 | -$77.59K derived: sum of 2 quarters · filed 2022-05-11 | -$124.54K derived: sum of 3 quarters · filed 2022-05-11 | |
| 2020-12-31 | -$35.54K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$82.48K derived: sum of 2 quarters · filed 2022-03-31 | -$98.13K 10-K · filed 2022-03-31 | |
| 2020-09-30 | -$46.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$62.60K 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | -$15.65K 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |